OSIRIS THERAPEUTICS INC NEW - COM (OSIR)

CUSIP: 68827R108

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM
Total 13F shares
6,828,207
Share change
+3,417,524
Total reported value
$129,727,000
Price per share
$19.00
Number of holders
56
Value change
+$67,294,978
Number of buys
40
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 68827R108?
CUSIP 68827R108 identifies OSIR - OSIRIS THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSIRIS THERAPEUTICS INC NEW - COM (OSIR) as of Q1 2019

As of 31 Mar 2019, OSIRIS THERAPEUTICS INC NEW - COM (OSIR) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,828,207 shares. The largest 10 holders included ALPINE ASSOCIATES MANAGEMENT INC., VANGUARD GROUP INC, GABELLI FUNDS LLC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, Cloverdale Capital Management, LLC, GOLDMAN SACHS GROUP INC, WATER ISLAND CAPITAL LLC, Beryl Capital Management LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 56 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.